Literature DB >> 9058545

A study of iron acquisition mechanisms of Legionella pneumophila grown in chemostat culture.

B W James1, W S Mauchline, P J Dennis, C W Keevil.   

Abstract

We recently demonstrated that the virulence of a clinical isolate of Legionella pneumophila is significantly attenuated when cultured in an iron-limited environment. In this study the influence of iron limitation on the expression of enzyme activities and iron-transport mechanisms was investigated. Expression of the important pathogenicity factor, the zinc metalloprotease, was reduced fivefold in response to iron limitation. Ferric citrate reductase activity was demonstrated in both iron-limited and replete cell fractions. Activity was located principally in the cytoplasm and periplasm, and was not enhanced by iron restriction. Optimum activity was observed with NADPH as reductant. Siderophores were not elaborated under these culture conditions. Iron-loaded transferrin enhanced the growth of steady-state, iron-limited cultures, demonstrating that transferrin represents a potentially important iron source for L. pneumophila in vivo. Although cell surface transferrin receptors were not detected, in vitro experiments demonstrated digestion of transferrin by the zinc metalloprotease activity of culture supernatants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058545     DOI: 10.1007/s002849900176

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  14 in total

1.  Discovery of a nonclassical siderophore, legiobactin, produced by strains of Legionella pneumophila.

Authors:  M R Liles; T A Scheel; N P Cianciotto
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

Review 2.  An update on iron acquisition by Legionella pneumophila: new pathways for siderophore uptake and ferric iron reduction.

Authors:  Nicholas P Cianciotto
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

3.  Involvement of minerals in adherence of Legionella pneumophila to surfaces.

Authors:  Mohamad Koubar; Marie-Hélène Rodier; Jacques Frère
Journal:  Curr Microbiol       Date:  2013-01-06       Impact factor: 2.188

4.  The Legionella pneumophila iraAB locus is required for iron assimilation, intracellular infection, and virulence.

Authors:  V K Viswanathan; P H Edelstein; C D Pope; N P Cianciotto
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  lbtA and lbtB are required for production of the Legionella pneumophila siderophore legiobactin.

Authors:  Kimberly A Allard; V K Viswanathan; Nicholas P Cianciotto
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

6.  Pasteurella multocida gene expression in response to iron limitation.

Authors:  M L Paustian; B J May; V Kapur
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  The Legionella pneumophila Siderophore Legiobactin Is a Polycarboxylate That Is Identical in Structure to Rhizoferrin.

Authors:  Denise M Burnside; Yuyang Wu; Saman Shafaie; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

8.  The cytochrome c maturation locus of Legionella pneumophila promotes iron assimilation and intracellular infection and contains a strain-specific insertion sequence element.

Authors:  V K Viswanathan; Sherry Kurtz; Lisa L Pedersen; Yousef Abu-Kwaik; Kevin Krcmarik; Sejal Mody; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

9.  Secreted pyomelanin of Legionella pneumophila promotes bacterial iron uptake and growth under iron-limiting conditions.

Authors:  Huaixin Zheng; Christa H Chatfield; Mark R Liles; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

10.  Poly-3-hydroxybutyrate in Legionella pneumophila, an energy source for survival in low-nutrient environments.

Authors:  B W James; W S Mauchline; P J Dennis; C W Keevil; R Wait
Journal:  Appl Environ Microbiol       Date:  1999-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.